Does Retrovir Interact with Lovotibeglogene Autotemcel?
CDI records a major classification for Retrovir and Lovotibeglogene Autotemcel. The stored summary is: Anti-retroviral medications may interfere with manufacturing of LYFGENIA. Discontinue at least one month prior to mobilization and until all cycles of apheresis are completed. Some long-acting anti-retrovirals may require longer discontinuation. The mechanism involves may interfere with manufacturing of lyfgenia. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This record was extracted from drug labeling through openFDA. NIH/NLM RxNorm is used for drug identities. The summary and severity classification are CDI's processed information, not a verbatim source quotation. Product, route, and patient circumstances matter.
- Severity
- Major
- Management
- Close medical supervision required
- Data Source
- U.S. FDA via OpenFDA
Recorded Mechanism
May interfere with manufacturing of LYFGENIA
What To Tell Your Doctor or Pharmacist
If you are taking Retrovir and your doctor is considering prescribing Lovotibeglogene Autotemcel (or vice versa), make sure to:
- Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
- Ask whether the benefits of combining these medications outweigh the risks for your specific situation
- Ask what symptoms to watch for that would indicate the interaction is causing problems
- Ask how frequently you should be monitored while these are co-prescribed
- Ask whether any dosage adjustments are needed
- Never stop or change either medication without first consulting your healthcare provider